Susceptibility locus for epidermodysplasia verruciformis not linked to cervical cancer in situ

Hereditas

Volumn 135, Issue 1, 2001, Pages 61-63

  Beskow, Anna H ^a   Rönnholm, Jessica ^a   Magnusson, Patrik K E ^a   Gyllensten, Ulf B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BIOPSY; CHROMOSOME 17Q; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA ISOLATION; EPIDERMODYSPLASIA VERRUCIFORMIS; FAMILIAL CANCER; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PSORIASIS; SWEDEN; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0036114870     PISSN: 00180661     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2001.00061.x     Document Type: Article

References (16)

1. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM and Wheeler CM, (1994). HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat. Genet. 6: 157-162.
2. Beskow AH and Gyllensten UB, (2001). HLA class II alleles associated with infection by HPV 16 in cervical cancer in situ. Int. J. Cancer 93: 817-822.
3. Cottingham RW, Idury RM and Schaffer AA, (1993). Faster sequential genetic linkage computations. Am. J. Hum. Genet. 53: 252-263.
4. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J and Weissenbach J, (1996). A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154.
5. Favre M, Orth G, Majewski S, Baloul S, Pura A and Jablonska S, (1998). Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J. Invest. Dermatol. 110: 311-317.
6. Jablonska S, Dabrowski J and Jakubowicz K, (1972). Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 32: 583-589.
7. Josefsson A, Livak K and Gyllensten U, (1999). Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J. Clin. Microbiol. 37: 490-496.
8. Josefsson A, Magnusson PKE and Gyllensten U, (1998). Human papillomavirus. In: Methods in Molecular Medicine: Molecular Protocols for Sexually Transmitted Diseases (eds RS Peeling and PF Sparline). Humana Press, p. 171-193.
9. Magnusson PK, Sparen P and Gyllensten UB, (1999). Genetic link to cervical tumours. Nature 400: 29-30.
10. Morton N, (1955). Sequential tests for the detection of linkage. Am. J. Hum. Genet. 7: 277-318.
11. Orth G, Jablonska S, Jarzabek-Chorzelska M, Obalek S, Rzesa G, Favre M and Croissant O, (1979). Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39: 1074-1082.
12. Ramoz N, Rueda LA, Bouadjar B, Favre M and Orth G, (1999). A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J. Invest. Dermatol. 112: 259-263.
13. Terwilliger JD, (1995). A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am. J. Hum. Genet. 56: 777-787.
14. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P and Menter A, (1994). Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264: 1141-1145.
15. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N, (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189: 12-19.
16. Wank R and Thomssen C, (1991). High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352: 723-725.